Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Genscript Biotech Corp (OP: GNNSF ) 1.400 UNCHANGED Last Price Updated: 9:30 AM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.400 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 1.400 Today's Range 1.400 - 1.400 52wk Range 1.050 - 3.200 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation? August 01, 2024 Key Takeaways: Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its... Via Benzinga Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal July 20, 2024 In recent news, South Korea’s SK Biopharma in-licensed global rights to a radiopharmaceutical compound developed by Full-Life Technologies of Shanghai in a $571 million deal. Via Talk Markets Performance YTD -32.37% -32.37% 1 Month -0.71% -0.71% 3 Month -12.50% -12.50% 6 Month -8.50% -8.50% 1 Year -50.79% -50.79% More News Read More Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Via Talk Markets 3 DNA Stocks to Buy for the Synthetic Biology Revolution May 14, 2023 Via InvestorPlace The Next Big Disruptors? 3 Biotech Stocks Making Headlines. February 17, 2023 Via InvestorPlace Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million January 21, 2023 Via Talk Markets Three Pharma Stocks to Sell Before They Die December 24, 2022 Via InvestorPlace Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact December 10, 2022 Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.